000 01482 a2200385 4500
005 20250514212815.0
264 0 _c20050214
008 200502s 0 0 eng d
022 _a0145-2126
024 7 _a10.1016/j.leukres.2004.05.023
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aOsuji, Nnenna
245 0 0 _aLessons from a case of T-cell large granular lymphocytic leukaemia suggesting that immunomodulatory therapy is more effective than intensive treatment.
_h[electronic resource]
260 _bLeukemia research
_cFeb 2005
300 _a225-8 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAlemtuzumab
650 0 4 _aAntibodies, Monoclonal
_xtherapeutic use
650 0 4 _aAntibodies, Monoclonal, Humanized
650 0 4 _aAntibodies, Neoplasm
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aImmunosuppressive Agents
_xpharmacology
650 0 4 _aImmunotherapy
_xmethods
650 0 4 _aLeukemia, T-Cell
_xdrug therapy
650 0 4 _aMale
650 0 4 _aMethotrexate
_xpharmacology
650 0 4 _aPeripheral Blood Stem Cell Transplantation
_xmethods
650 0 4 _aT-Lymphocytes
_xdrug effects
700 1 _aMatutes, Estella
700 1 _aWotherspoon, Andrew
700 1 _aCatovsky, Daniel
773 0 _tLeukemia research
_gvol. 29
_gno. 2
_gp. 225-8
856 4 0 _uhttps://doi.org/10.1016/j.leukres.2004.05.023
_zAvailable from publisher's website
999 _c15289357
_d15289357